Report Highlights
The global MRCAS market was valued at nearly $2.2 billion in 2011 and should reach nearly $2.4 billion in 2012. Total market value is expected to reach nearly $4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 10.6%.
Report Scope
This report is an analytical business tool with the primary purpose of describing the MRCAS equipment industry and the global market for these devices. MRCAS equipment is defined as computer- or microprocessor-enabled devices and accessories that are physically situated in the operating room and directly assist the surgeon in planning and carrying out surgical procedures. Thus, the scope of the study does not include:
- Devices that provide images and other information but are not an integral part of the MRCAS system, such as preoperative imaging (e.g., CT, MRI) equipment or laboratory and other analytical devices.
- Computerized medical records systems.
- Electronic operating room equipment such as heart monitors that enable the surgical team to monitor the patient’s condition but do not assist the surgeon directly in carrying out the operation.
- Other nonelectronic operating room equipment.
The format of the study is organized around the following topics:
- Major types and applications of MRCAS.
- Industry structure.
- Market size and segmentation, including historical data on sales by application, product type and geographical market.
- Market drivers.
- Detailed market projections through 2017.
- Competition and market shares.
- Observations and conclusions regarding the future of the MRCAS market.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
The global market for medical robotics and computer-assisted surgical equipment was worth nearly $2 billion in 2010. The market is projected to be $2.1 billion in 2011 and $3.6 billion by 2016 for a CAGR of 11.1% between 2011 and 2016.
Report Highlights
- The U.S. market for medical robotics and computer-assisted surgical equipment was worth an estimated $648 million in 2008. The market is projected to reach $676 million in 2009 and $1.5 billion by 2014, a CAGR of 17.7%.
- Surgical robot systems were the largest product segment of the market in 2008 with a 54% market share. With a projected average annual growth rate of more than 23% between 2009 and 2014, surgical robots are expected to increase their share of the US MRCAS market to 65% by 2014.
- In terms of surgical applications, orthopedic surgical applications are projected to grow at a CAGR of 42.6% between 2009 and 2014, and are expected to account for 22% of the market by 2014.
Report Highlights
-
The U.S. market for medical robotics and computer-assisted surgical equipment was worth an estimated $564 million in 2005. The market is projected to reach $704 million in 2006 and $2.8 billion by 2011, an average annual growth rate (AAGR) of 31.4%.
-
Surgical navigation systems were the largest product segment (53%) of the U.S. MRCAS market in 2005. However, surgical robots are the fastest growing U.S. market segment, with a projected AAGR of over 43% between 2006 and 2011.
-
In terms of surgical applications, neurosurgical applications accounted for the bulk of the U.S. MRCAS market-approximately 40%-in 2005. Endoscopic surgical applications are the fastest-growing application segment, and are expected account for a market-leading 45% of the U.S. market by 2011.
-
The total worldwide market for MRCAS devices and equipment is expected to be $1.3 billion in 2006 and $5.7 billion by 2011, an AAGR of 34.7%.
Report Highlights
-
U.S. MRCAS market will grow at more than 22% annually on average reaching $673 million by 2007.
-
Surgical robots are the fastest-growing U.S market segment.
-
Sales of surgical robots should reach $220 million in 2007.
-
Endoscopic surgical applications are the fastest-growing application segment.
Related Reports
Global Markets and Technologies for Medical Lasers
The global market for medical laser devices was $2.7 billion in 2010. As it recovers from the effects of the recent recession, the market is expected to increase to more than $3 billion in 2011 and $6.8 billion in 2016, a compound annual growth rate (CAGR) of 17.3% over the 5-year period.
Medical Automation Technologies, Products and Markets
The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.
The Market for Minimally Invasive Medical Devices
The global market for MIS devices and instruments was worth an estimated $13.4 billion in 2010. The market is expected to reach $14.4 billion in 2011 and $21.1 billion by 2016, a compound annual growth rate (CAGR) of 7.9% between 2011 and 2016.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More